Prospective Ultrafast MRI Radiomics for Breast Cancer

CompletedOBSERVATIONAL

Enrollment

225

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

August 31, 2023

Conditions

Breast Cancer

Interventions

DIAGNOSTIC_TEST

MRI

MRI based classification of breast cancer histological factors and subtypes

Trial Locations (1)

Bo Kyoung Seo, Ansan

All Listed Sponsors

lead

Korea University Ansan Hospital

OTHER

NCT06104189 - Prospective Ultrafast MRI Radiomics for Breast Cancer | Biotech Hunter | Biotech Hunter